Monash IVF shares soar most since 2014 after takeover offerCheyanne EncisoThe NightlyMon, 24 November 2025 9:28AMCommentsCommentsEmail Cheyanne Enciso
Australia’s Monash IVF rose the most since 2014 after saying it had rejected a takeover bid from Genesis Capital Investment Management and Washington H. Soul Pattinson and Co.
The pioneering reproductive health-care company said Monday that it had “received an opportunistic, unsolicited, conditional and non-binding indicative proposal” from the consortium. Shares soared 39 per cent as of 10.36am in Sydney.
Monash IVF’s board considered the offer but unanimously decided that it undervalued the company and wasn’t in shareholders’ best interest, the firm said in a statement.
Among its concerns was that the offer price was at a substantial discount to comparable IVF transactions in the Australian market, it added.
“The board has therefore determined to reject the proposal in its current form,” Monash IVF said.
The offer comes after two embryo transfer mix-ups earlier this year sent the company’s shares tumbling and rattled investor confidence. Former chief executive Michael Knaap resigned in June.
Monash IVF pioneered the world’s first IVF pregnancy in the 1970s.
Bloomberg
Get the latest news from thewest.com.au in your inbox.
Sign up for our emails
Read more on The West Australian
